Q1 FY27 — 10 Aug 2026
Shaily Engineering Plastics Limited Q1 FY27
Shaily Engineering Plastics Limited reported a strong Q1 FY27 with consolidated revenue growing 14% and EBITDA up 18%, driven primarily by an 85% surge in its Healthcare segment. The company successfully secured new orders for injector pens and expanded its global business development team. While the Consumer segment faced headwinds from softer demand, management expects gross margins to normalize and is confident in its full-year guidance, with significant progress on new product development and capacity expansion.
Read the full call






